BioNTech

China stocks mixed
Markets

China stocks mixed

SHANGHAI: China stocks wavered with no clear direction on Monday, as losses in tech shares amid Beijing’s ...
Published 11 May, 2021 04:39am
Global pharma shares sink as Biden backs COVID-19 vaccine IP waiver
Markets

Global pharma shares sink as Biden backs COVID-19 vaccine IP waiver

  • "The production of mRNA vaccines is not just about intellectual property. A lot of other things are in play, such as manufacturing know-how and capacity. Other companies or countries are unlikely to produce mRNA shots quickly," he said.
  • Several pharmaceutical analysts said IP waivers may on the surface help a world facing a pandemic, but manufacturing the vaccines was a barrier.
Published 06 May, 2021 08:28pm
Pfizer expands production as quarterly earnings surge to $3.5 billion
World

Pfizer expands production as quarterly earnings surge to $3.5 billion

  • Pfizer has earned $3.5 billion in the first quarter of 2021, as the ramped up sales of the COVID-19 vaccine boosted its projected annual earnings to $26 billion.
  • The American pharmaceutical company announced on Tuesday that it has raised its annual revenue guidance to up to $72.5 billion, up from $61.4 billion, predominantly due to the contractual delivery of 1.6 billion vaccine doses in 2021.
Published 05 May, 2021 10:40am
Pfizer and BioNTech request EU to approve vaccine for 12 to 15 year olds
World

Pfizer and BioNTech request EU to approve vaccine for 12 to 15 year olds

  • Pfizer and BioNTech will be seeking approval from the European Medicines Agency (EMA) to approve their coronavirus vaccine for use on 12-15 year olds.
  • The companies articulated that the children will continue to be monitored for longer-term protection and safety for an additional two years.
Updated 30 Apr, 2021 05:19pm